Stay updated with breaking news from Alzheimers Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Annovis Bio, Inc. (ANVS) are up 16% on Thursday after the company shared positive news about its Alzheimer's study. ANVS is trading on the New York Stock Exchange at $9.
Filmmaker Vishaal Nityanand got involved with the issue of Alzheimer’s disease in 2013 when he came across a few real cases in different parts of India, of senior Alzheimer patients being shunned by their families. “All families are not the same, but our system is so insensitive towards such grave health challenges faced by the […]
A new study suggests that following a healthy lifestyle is linked to slower memory decline in older adults, even in people with the apolipoprotein E4 (APOE4) gene—one of the strongest known risk factors for Alzheimer’s disease and related dementias.